Enovix Corporation (NASDAQ:ENVX) Given Average Rating of “Moderate Buy” by Brokerages

Enovix Corporation (NASDAQ:ENVX) has earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $15.65.

ENVX has been the subject of a number of recent research reports. TD Cowen lowered their price objective on shares of Enovix from $15.00 to $7.50 and set a “hold” rating for the company in a research report on Thursday. Northland Securities set a $16.00 target price on Enovix in a report on Monday, November 17th. Cantor Fitzgerald dropped their price target on Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Enovix in a report on Monday, December 29th. Finally, Craig Hallum reduced their price objective on Enovix from $16.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday.

Enovix Stock Down 11.4%

ENVX stock opened at $5.27 on Monday. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of -6.84 and a beta of 2.15. Enovix has a 1-year low of $5.24 and a 1-year high of $16.49. The firm has a fifty day moving average price of $7.10 and a two-hundred day moving average price of $8.87. The company has a debt-to-equity ratio of 1.90, a current ratio of 8.34 and a quick ratio of 8.13.

Institutional Trading of Enovix

Several hedge funds have recently bought and sold shares of the company. Jupiter Asset Management Ltd. acquired a new stake in shares of Enovix in the third quarter valued at approximately $2,465,000. Perennial Investment Advisors LLC increased its position in Enovix by 50.2% in the 2nd quarter. Perennial Investment Advisors LLC now owns 366,100 shares of the company’s stock valued at $3,785,000 after acquiring an additional 122,278 shares during the period. XTX Topco Ltd acquired a new stake in Enovix in the 2nd quarter valued at approximately $1,107,000. Baird Financial Group Inc. raised its stake in Enovix by 24.0% during the 2nd quarter. Baird Financial Group Inc. now owns 721,930 shares of the company’s stock valued at $7,465,000 after acquiring an additional 139,617 shares in the last quarter. Finally, Electron Capital Partners LLC boosted its position in Enovix by 5.3% during the 2nd quarter. Electron Capital Partners LLC now owns 7,066,293 shares of the company’s stock worth $73,065,000 after acquiring an additional 353,530 shares during the period. 50.92% of the stock is currently owned by institutional investors.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Q4 results beat expectations: revenue of ~$11.3M (+~16% YoY) topped estimates and EPS/loss was slightly better than forecast; gross profit and operating-loss improvement were highlighted on the call — a fundamental bright spot supporting longer‑term growth potential. SA Q4 Presentation
• Positive Sentiment: Multiple outlets noted the revenue and EPS beats and operational improvement (higher gross profit, narrower operating loss), which help the growth narrative even as profitability remains distant. Yahoo Finance: Q4 Report
• Neutral Sentiment: Unusual options activity: a large block of call buying (≈31,896 calls) indicates speculative/leveraged interest that may amplify intraday moves but doesn’t change fundamentals. AAII Options Note
• Neutral Sentiment: Some analysts lowered price targets but kept constructive ratings (e.g., Canaccord trimmed its PT but remains “Buy”), which mutes upside while signaling continued long‑term conviction from parts of the sell‑side. Benzinga: Canaccord Note
• Negative Sentiment: Near‑term guidance disappointed: Q1 FY2026 revenue guidance ($6.5M–$7.5M) came in well below consensus (~$8.8M), a key proximate reason for selling pressure as it implies slower near‑term growth. Company Press Release / Deck
• Negative Sentiment: Analyst downgrades/target cuts: TD Cowen cut its target sharply and moved to “Hold,” and other firms trimmed targets — increasing near‑term downside risk as sell‑side expectations are reset. Benzinga: TD Cowen Note
• Negative Sentiment: New risk disclosure highlights rising geopolitical/trade exposure (U.S.–China tensions) that could pressure supply chains and margins — a fresh governance/operational risk investors must price in. TipRanks: Risk Disclosure
• Negative Sentiment: Balance‑sheet and liquidity signals are concerning to some investors: cash fell year‑over‑year and total liabilities rose materially; coupled with insider sales called out in reporting, that has likely amplified selling. Quiver Quant: Financials

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.